Skip to content
Toggle main navigation
PURPOSE logo
PURPOSE logo
  • Home
  • Events
  • Opportunities
  • News & Publications
  • T90/R90 HEAL Pain Cohort Program
  • Mobile App
  • About
  • Exhibit
  • Affiliate Networks
    • Music4Pain (U24)
    • ENSEMBLE Network (U24)
    • Pain Research Forum (PRF)
    • ForceNET (U24)
    • NeuronS_MATTR (U24)
    • SPINEWORK Network (U24)
    Log in
    Request to Join

    News & Publications

    Do you have news or publications to share with the PURPOSE Network? Submit your news below.

    Submit Your News or Publication
    All
    Acquired Cognitive Impairment
    Acupuncture
    Addiction
    Ageing
    Alcohol Use / Alcohol Use Disorder (AUD)
    Analgesics
    Analgesics, Topical
    Anatomy
    Anesthesia, General
    Anesthesia, Intravenous regional
    Anesthesia, Local
    Anesthesia, Spinal
    Animal Models
    Anxiety
    Arthritis, Rheumatoid
    See all

    Highlighted News

    Results (51)

    Prefrontal rTMS modulates dynamic expectancy processes to shape subsequent pain experience

    Prefrontal rTMS modulates dynamic expectancy processes to shape subsequent pain experience

    Neurotherapeutics. 2026 Oct 28;24(1):e01107. doi: 10.1016/j.neurot.2026.e01107. Online ahead of print.ABSTRACTPain expectancy is a major determinant of pain perception, and identifying effective approaches to modulate expectancy may provide new opportunities for pain intervention. High-frequency repetitive transcranial magnetic stimulation (rTMS) targeting the dorsolateral prefrontal cortex (DLPFC
    October 29, 2026
    Post-approval modification of high-risk chronic pain devices approved through the FDA premarket approval pathway, 1981-2023

    Post-approval modification of high-risk chronic pain devices approved through the FDA premarket approval pathway, 1981-2023

    Expert Rev Med Devices. 2026 Oct 28. doi: 10.1080/17434440.2026.2750118. Online ahead of print.ABSTRACTBACKGROUND: High-risk chronic pain devices undergo postapproval modifications via supplement pathways with varying evidentiary requirements, but their extent has not been systematically characterized.METHODS: Cross-sectional analysis of PMA-approved chronic pain devices (1981-2023) using suppleme
    October 28, 2026
    The efficacy of transcutaneous electrical nerve stimulation as an adjunctive therapy for perioperative pain management after total knee arthroplasty: an umbrella review

    The efficacy of transcutaneous electrical nerve stimulation as an adjunctive therapy for perioperative pain management after total knee arthroplasty: an umbrella review

    J Orthop Traumatol. 2026 Jul 22;27(1):62. doi: 10.1186/s10195-026-00957-z.ABSTRACTBACKGROUND: Total knee arthroplasty (TKA) is a cornerstone intervention for end-stage knee pathologies, yet acute postoperative pain remains a critical barrier to rehabilitation. Transcutaneous electrical nerve stimulation (TENS), a non-pharmacological adjunct, has potential for pain mitigation, but its efficacy lack
    October 22, 2026
    U.S. Veterans with Low Back Pain Benefit from Transcranial Direct Current Stimulation: Results from a Cognitive Behavioral Therapy Randomized Controlled Trial

    U.S. Veterans with Low Back Pain Benefit from Transcranial Direct Current Stimulation: Results from a Cognitive Behavioral Therapy Randomized Controlled Trial

    J Pain. 2026 Sep 5:106434. doi: 10.1016/j.jpain.2026.106434. Online ahead of print.ABSTRACTChronic low back pain is common among Veterans and is associated with functional impairment and prescription opioid misuse. Cognitive Behavioral Therapy for Chronic Pain is the VA's recommended nonpharmacologic treatment, yet many patients experience modest improvements, underscoring the need for adjunctive
    October 16, 2026
    Peripheral Neuromodulation for Central Pain: A Case of Thalamic Pain Syndrome Managed With Percutaneous Nerve Stimulation

    Peripheral Neuromodulation for Central Pain: A Case of Thalamic Pain Syndrome Managed With Percutaneous Nerve Stimulation

    Pain Med Case Rep. 2026 Sep;10(7):613-616.ABSTRACTBACKGROUND: Thalamic pain syndrome is a debilitating neuropathic condition that may develop after a thalamic stroke. Patients experience diffuse whole-body pain, contralateral to their stroke, that is often refractory to standard therapies.CASE REPORT: A 53-year-old woman with a history of right basal ganglia and thalamic hemorrhagic stroke present
    October 15, 2026
    A Novel Case Report of Closed-Loop Spinal Cord Stimulation for Neuropathic Pain in Cervical Spinal Cord Injury

    A Novel Case Report of Closed-Loop Spinal Cord Stimulation for Neuropathic Pain in Cervical Spinal Cord Injury

    Pain Med Case Rep. 2026 Sep;10(7):607-611.ABSTRACTBACKGROUND: Neuropathic pain after spinal cord injury (SCI) is common and often refractory. Closed-loop spinal cord stimulation (CL-SCS) is a novel intervention that adjusts stimulation based on evoked compound action potentials in real time, but its use for pain in complete SCI is not well described.CASE REPORT: A 45-year-old man with complete C6-
    October 15, 2026
    Progress in pain mechanisms and management

    Progress in pain mechanisms and management

    Signal Transduct Target Ther. 2026 Oct 13;11(1):444. doi: 10.1038/s41392-026-02931-x.ABSTRACTPain is a multifaceted sensory and emotional experience that profoundly affects human health and quality of life. It functions as a double-edged sword: while acute pain serves as a protective warning signal, chronic pain compromises physiological and psychological well-being. Pain is now widely regarded as
    October 13, 2026
    Combination spinal cord stimulation at different frequencies produces sustained pain relief with immune activation

    Combination spinal cord stimulation at different frequencies produces sustained pain relief with immune activation

    bioRxiv [Preprint]. 2026 Aug 12:2026.08.06.742589. doi: 10.64898/2026.08.06.742589.ABSTRACTSpinal cord stimulation (SCS) is an established therapy for neuropathic pain, typically delivered at either low (60 Hz) or high (1 kHz) frequencies, with analgesic effects largely dependent on active stimulation. Here, we investigated whether combined-frequency SCS produces sustained analgesia beyond stimula
    October 8, 2026
    Spinal cord stimulation in the treatment of chronic pain: from evidence to clinical practice - part 1

    Spinal cord stimulation in the treatment of chronic pain: from evidence to clinical practice - part 1

    Neurol Neurochir Pol. 2026 Oct 8. doi: 10.5603/pjnns.111689. Online ahead of print.ABSTRACTINTRODUCTION: Neuropathic pain is caused by a lesion or disease of the somatosensory nervous system. Pharmacotherapy remains the primary treatment for this condition, although non-pharmacological modalities such as physical and psychological therapy are also recommended.STATE OF THE ART: Due to the limited e
    October 8, 2026
    Now Available: HEAL Initiative: Whole Joint Health Program (R61/R33) NOFO - Q& A

    Now Available: HEAL Initiative: Whole Joint Health Program (R61/R33) NOFO - Q& A

    New Video Available: HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) - Question & AnswerWatch the Q&A now in the Media CenterAlex H. Tuttle and Erin Burke Quinlan presented on the upcoming NIH HEAL Initiative Whole Joint Health Program (R61/R33) (PAR-27-045), and answered questions.Presenters:Alex H. Tuttle, PhD | Acting Deputy Branch Chief, Basic and Mechanistic Rese
    October 7, 2026
    Transcutaneous Electrical Acupoint Stimulation to Prevent Ipsilateral Shoulder Pain After Video-Assisted Thoracoscopic Surgery: A Multicenter Randomized Controlled Trial Protocol

    Transcutaneous Electrical Acupoint Stimulation to Prevent Ipsilateral Shoulder Pain After Video-Assisted Thoracoscopic Surgery: A Multicenter Randomized Controlled Trial Protocol

    J Pain Res. 2026 Sep 30;19:627058. doi: 10.2147/JPR.S627058. eCollection 2026.ABSTRACTBACKGROUND: Ipsilateral shoulder pain (ISP) after video-assisted thoracoscopic (VATS) surgery is common, distinct from incisional pain, and frequently overlooked in clinical practice. Transcutaneous electrical acupoint stimulation (TEAS) is a non-invasive, safe non-pharmacological analgesic modality. This trial p
    October 5, 2026
    Transcutaneous Auricular Vagus Nerve Stimulation for Chronic Pain Management: A Narrative Review

    Transcutaneous Auricular Vagus Nerve Stimulation for Chronic Pain Management: A Narrative Review

    Curr Neuropharmacol. 2026 Sep 29. doi: 10.2174/011570159X503412260915114332. Online ahead of print.ABSTRACTChronic pain represents a global public health challenge; current therapeutic interventions remain limited and are frequently accompanied by adverse effects. Transcutaneous auricular Vagus Nerve Stimulation (taVNS) has emerged in recent years as a potential non-invasive neuromodulation therap
    October 1, 2026
    Peripheral Nerve Stimulation for Intractable Chronic Pain: Real-World Clinical Outcomes, Utilization, and Economic Impact (PNS IMPACT Study)

    Peripheral Nerve Stimulation for Intractable Chronic Pain: Real-World Clinical Outcomes, Utilization, and Economic Impact (PNS IMPACT Study)

    Pain Physician. 2026 Sep;29(6):429-443.ABSTRACTBACKGROUND: Chronic pain imposes a substantial clinical and economic burden, as many patients undergo repeated procedures and high-risk opioids without durable relief, driving persistent health care costs and resource utilization.OBJECTIVES: To evaluate whether established clinical outcomes can be replicated in real-world practice and to assess health
    September 28, 2026
    Mechanisms and clinical application of photobiomodulation in pain therapy: a mini review

    Mechanisms and clinical application of photobiomodulation in pain therapy: a mini review

    Front Pain Res (Lausanne). 2026 Aug 18;7:1920821. doi: 10.3389/fpain.2026.1920821. eCollection 2026.ABSTRACTChronic pain remains a major clinical challenge, creating a need for safe, non-pharmacological interventions. This narrative mini-review examines two light-based approaches that differ in their sites of action and treatment parameters: visual-light exposure and local red or near-infrared lig
    September 2, 2026
    Electromagnetic neuromodulation for chronic pain: historical context, contemporary modalities, and evidence gaps

    Electromagnetic neuromodulation for chronic pain: historical context, contemporary modalities, and evidence gaps

    Front Pain Res (Lausanne). 2026 Aug 18;7:1901466. doi: 10.3389/fpain.2026.1901466. eCollection 2026.ABSTRACTElectromagnetic neuromodulation is increasingly used as an adjunct or alternative to pharmacologic therapy for pain, with several approaches cleared for select indications and many others under active investigation. We review implanted neuromodulation approaches (intracranial and spinal), va
    September 2, 2026
    Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain

    Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain

    Cochrane Database Syst Rev. 2026 Aug 24;8:CD016383. doi: 10.1002/14651858.CD016383.ABSTRACTThis is a protocol for a Cochrane review (intervention). The objectives are as follows: To evaluate the benefits and harms of transcutaneous electrical nerve stimulation (TENS), used alone or as an adjunct to other interventions, compared with sham TENS, placebo, no treatment, or other clinical interventions
    August 24, 2026
    Targeting Central Sensitization for Pain Management in Knee Osteoarthritis: A Narrative Review of Mechanisms and Clinical Applications of Neuromodulation

    Targeting Central Sensitization for Pain Management in Knee Osteoarthritis: A Narrative Review of Mechanisms and Clinical Applications of Neuromodulation

    J Pain Res. 2026 Aug 19;19:627874. doi: 10.2147/JPR.S627874. eCollection 2026.ABSTRACTChronic refractory pain in knee osteoarthritis (KOA) is among the leading causes of physical disability worldwide. While KOA is traditionally characterized by articular cartilage degradation, subchondral bone remodeling, synovial inflammation, and periarticular soft tissue lesions, the structural damage frequentl
    August 24, 2026
    Cancer pain

    Cancer pain

    Nat Rev Dis Primers. 2026 Aug 20;12(1):55. doi: 10.1038/s41572-026-00730-w.ABSTRACTCancer pain is a persistent and multifaceted global health problem that profoundly impairs quality of life, function and prognosis. Cancer pain occurs across all cancer types and stages, including in long-term survivors, with prevalence and severity influenced by tumour location, treatment modality, metastatic burde
    August 21, 2026
    Long Term Pain Reduction and Explantation Rates of Spinal Cord Stimulation: A Systematic Review and Meta-Analysis

    Long Term Pain Reduction and Explantation Rates of Spinal Cord Stimulation: A Systematic Review and Meta-Analysis

    Neuromodulation. 2026 Jul 18:S1094-7159(26)01306-1. doi: 10.1016/j.neurom.2026.07.642. Online ahead of print.ABSTRACTBACKGROUND: Spinal Cord Stimulation (SCS) is a therapeutic option for chronic pain conditions, such as persistent spinal pain syndrome, complex regional pain syndrome, painful diabetic peripheral neuropathy, and radiculopathy. The treatment typically involves a temporary trial phase
    August 11, 2026
    Molecular Inflammatory Characteristics of Patients With Chronic Pain Under Burst Spinal Cord Stimulation: An Exploratory Study

    Molecular Inflammatory Characteristics of Patients With Chronic Pain Under Burst Spinal Cord Stimulation: An Exploratory Study

    Neuromodulation. 2026 Jul 6:S1094-7159(26)00633-1. doi: 10.1016/j.neurom.2026.06.472. Online ahead of print.ABSTRACTOBJECTIVES: Spinal cord stimulation (SCS) has been reported to reduce chronic back and leg pain and improve functional capacity. However, its mechanism of action is not completely understood. One proposed mechanism involves the modulation of central and peripheral inflammatory circui
    July 23, 2026
    Contact
    Neurovations Education
    [email protected]

    United States

    PURPOSE@PainResearchers.com
    707-260-0848
    Links
    • NIH HEAL Initiative
    • Research in Pain Management